Lipoproteins and cardiovascular risk.
作者信息
Ravnskov Uffe
出版信息
Lancet. 2003 Jun 7;361(9373):1988-9; author reply 1989. doi: 10.1016/S0140-6736(03)13565-9.
Abstract
摘要
相似文献
1
Lipoproteins and cardiovascular risk.
Lancet. 2003 Jun 7;361(9373):1988-9; author reply 1989. doi: 10.1016/S0140-6736(03)13565-9.
2
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.载脂蛋白与脂质作为冠状动脉风险指标及他汀类药物治疗靶点的比较
Lancet. 2003 Mar 1;361(9359):777-80. doi: 10.1016/s0140-6736(03)12663-3.
3
Statins and regression of coronary atherosclerosis.
JAMA. 2007 May 23;297(20):2197; author reply 2197. doi: 10.1001/jama.297.20.2197-a.
4
Cholesterol, lipids, and statins.胆固醇、脂质与他汀类药物。
Tex Heart Inst J. 2005;32(3):378-9.
5
Optimal lipids, statins, and dementia.最佳血脂水平、他汀类药物与痴呆症
J Am Coll Cardiol. 2005 Mar 15;45(6):963-4; author reply 964-5. doi: 10.1016/j.jacc.2004.12.019.
6
Med could reverse arterial blockages.Med可以逆转动脉阻塞。
Health News. 2006 Jul;12(7):13.
7
[Aggressive statin therapy reduces the progression of atherosclerosis-- DMW15/2005].强化他汀治疗可减缓动脉粥样硬化进展——DMW15/2005
Dtsch Med Wochenschr. 2006 Mar 3;131(9):460; author reply 460. doi: 10.1055/s-2006-932546.
8
Serum HDL-Cholesterol Level Does Not Influence Cardiovascular Event Rate under Sufficient Lowering of LDL-Cholesterol by Pitavatatin in Patients with Stable Coronary Artery Disease.在稳定型冠状动脉疾病患者中，匹伐他汀充分降低低密度脂蛋白胆固醇的情况下，血清高密度脂蛋白胆固醇水平不影响心血管事件发生率。
J Atheroscler Thromb. 2022 Jan 1;29(1):8-10. doi: 10.5551/jat.ED165. Epub 2021 Mar 24.
9
Pitavastatin: novel effects on lipid parameters.匹伐他汀：对血脂参数的新作用。
Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X.
10
Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy.低高密度脂蛋白胆固醇与心血管疾病：他汀类药物治疗降低风险
Am Heart J. 2006 Mar;151(3):556-63. doi: 10.1016/j.ahj.2005.03.049.
Zotero 插件